Pulmonx Corporation LUNG Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's financing cash flow?
- Pulmonx Corporation (LUNG) reported financing cash flow of $2.03M in Q1 2026.
- How has Pulmonx Corporation's financing cash flow changed year-over-year?
- Pulmonx Corporation's financing cash flow increased by 205.1% year-over-year, from $664K to $2.03M.
- What is the long-term trend for Pulmonx Corporation's financing cash flow?
- Over 4 years (2021 to 2025), Pulmonx Corporation's financing cash flow has grown at a -33.0% compound annual growth rate (CAGR), from $4.46M to $900K.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.